PRPH
ProPhase Labs, Inc.
OTC Markets OTCIDUSDEQUITY
Healthcare
DELAYED
Last price
0.02
▼ 0.01 (33.33%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
0.02
Prev close
0.03
Day high
0.03
Day low
0.03
Volume
74.11K
Market cap
$280.32K
P/E (TTM)
—
52W range
0.02 – 6.70
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
331.96K
Total on file
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-50.00%
-48.6%
1M
-66.67%
-70.4%
3M
-77.78%
-80.9%
6M
-87.50%
-98.6%
YTD
-95.56%
-107.8%
1Y
-99.39%
-119.4%
3Y
-99.96%
-174.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$280.32K
Enterprise value$9.49M
Revenue (TTM)$3.85M
Gross profit$645.00K
EBITDA$-11.63M
Net income$-22.46M
EPS (TTM)$-1.85
Free cash flow$47.79M
Total cash$20.00K
Total debt$9.12M
Book value / share$-0.04
Shares outstanding14.02M
Float15.22M
Short % of float0.71%
Dividend yield—
Beta (5Y)—
Short interest
Shares short
30.02K
Prior 8.96K
Change vs prior
+235.0%
Shorts adding
% of float
0.71%
Normal
% of shares out
0.65%
Against total outstanding
Days to cover
0.1
Liquid
Float
15.22M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E—
Forward P/E0.04
PEG ratio—
Price / sales—
Price / book—
EV / revenue2.47
EV / EBITDA-0.82
Gross margin16.77%
Operating margin-261.62%
Profit margin0.00%
Return on equity-539.65%
Return on assets-19.56%
Debt / equity—
Current ratio0.05
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $4.34M | $6.77M | $34.98M | $122.65M | -35.8% |
| Operating revenue | $4.34M | $6.77M | $34.98M | $122.65M | -35.8% |
| Cost of revenue | $2.96M | $6.92M | $19.43M | $51.99M | -57.2% |
| Gross profit | $1.38M | -$150.00K | $15.56M | $70.65M | +1,022.7% |
| Research & development | $107.00K | $594.00K | $1.40M | $652.00K | -82.0% |
| Selling, general & admin | $19.32M | $37.88M | $33.44M | $34.38M | -49.0% |
| Total operating expense | $19.43M | $38.48M | $36.78M | $47.06M | -49.5% |
| Operating income | -$18.05M | -$38.63M | -$21.22M | $23.59M | +53.3% |
| Net interest income | -$6.93M | -$3.35M | -$1.19M | -$611.00K | -107.0% |
| Pre-tax income | -$23.39M | -$42.33M | -$22.40M | $22.91M | +44.8% |
| Tax provision | $0 | $7.20M | -$6.02M | $4.45M | -100.0% |
| Net income to common | -$14.74M | -$53.36M | -$16.78M | $18.46M | +72.4% |
| Basic EPS | -1.74 | -26.68 | -9.80 | 11.70 | +93.5% |
| Diluted EPS | -1.74 | -26.68 | -9.80 | 10.20 | +93.5% |
| EBIT | -$16.45M | -$38.98M | -$21.13M | $23.67M | +57.8% |
| EBITDA | -$11.39M | -$32.34M | -$14.66M | $28.73M | +64.8% |
| Basic shares | 8.49M | 2.99M | 1.72M | 1.58M | +184.2% |
| Diluted shares | 8.49M | 2.99M | 1.72M | 1.87M | +184.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $90.00K | $678.00K | $1.61M | $9.11M | — | -86.7% |
| Cash & short-term investments | $90.00K | $678.00K | $4.74M | $17.44M | — | -86.7% |
| Accounts receivable | $2.56M | $34.90M | $39.68M | $37.57M | — | -92.7% |
| Inventory | $70.00K | $1.14M | $2.29M | $3.98M | — | -93.9% |
| Total current assets | $3.15M | $30.64M | $47.59M | $60.83M | — | -89.7% |
| Property, plant & equipment | $2.03M | $11.62M | $14.90M | $11.35M | — | -82.5% |
| Goodwill & intangibles | $11.13M | $14.98M | $17.56M | $14.18M | — | -25.7% |
| Total assets | $59.87M | $63.20M | $91.93M | $87.65M | — | -5.3% |
| Total current liabilities | $53.08M | $32.13M | $20.86M | $16.07M | — | +65.2% |
| Current debt | $5.16M | $3.21M | — | — | — | +60.7% |
| Long-term debt | — | $11.65M | $7.33M | $2.40M | $10.04M | — |
| Total debt | $8.62M | $24.57M | $18.46M | $6.96M | — | -64.9% |
| Total liabilities | $56.36M | $55.85M | $42.54M | $24.02M | — | +0.9% |
| Retained earnings | -$73.14M | -$58.39M | -$5.03M | $11.75M | — | -25.2% |
| Shareholder equity | $3.51M | $7.35M | $49.38M | $63.63M | — | -52.3% |
| Working capital | -$49.93M | -$1.50M | $26.73M | $44.76M | — | -3,235.4% |
| Net tangible assets | -$7.63M | -$7.63M | $31.82M | $49.45M | — | +0.0% |
| Shares issued | 9.84M | 4.28M | 3.70M | 3.43M | — | +129.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$23.39M | -$49.52M | -$16.38M | $18.46M | — | +52.8% |
| Depreciation & amortisation | $5.06M | $6.64M | $6.47M | $5.06M | — | -23.9% |
| Stock-based compensation | $1.89M | $3.64M | $3.54M | $3.99M | — | -48.0% |
| Change in working capital | -$185.00K | $14.89M | -$6.72M | -$4.34M | — | -101.2% |
| Operating cash flow | -$8.34M | -$17.54M | -$11.89M | $28.55M | — | +52.4% |
| Capital expenditure | — | -$906.00K | -$2.08M | -$3.92M | -$4.23M | — |
| Investing cash flow | $920.00K | $2.42M | -$1.37M | -$2.08M | — | -62.0% |
| Share buybacks | — | $0 | -$5.97M | -$9.63M | -$917.00K | — |
| Dividends paid | — | — | $0 | -$9.35M | -$4.55M | — |
| Financing cash flow | $6.84M | $14.19M | $5.76M | -$26.02M | — | -51.8% |
| Free cash flow | -$8.34M | -$18.44M | -$13.97M | $24.63M | — | +54.8% |
| End cash position | $90.00K | $678.00K | $1.61M | $9.11M | — | -86.7% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.17M | $784.00K | $883.00K | $1.25M | $1.43M | +49.1% |
| Operating revenue | $1.17M | $784.00K | $883.00K | $1.25M | $1.43M | +49.1% |
| Cost of revenue | $874.00K | $537.00K | $1.01M | $513.00K | $905.00K | +62.8% |
| Gross profit | $295.00K | $247.00K | -$123.00K | $734.00K | $526.00K | +19.4% |
| Research & development | $0 | $0 | $6.00K | $4.00K | $97.00K | — |
| Selling, general & admin | $2.72M | $5.97M | $4.63M | $4.62M | $4.09M | -54.4% |
| Total operating expense | $2.72M | $5.97M | $4.64M | $4.63M | $4.19M | -54.4% |
| Operating income | -$2.43M | -$5.73M | -$4.76M | -$3.89M | -$3.66M | +57.6% |
| Net interest income | -$651.00K | -$4.26M | -$1.55M | -$587.00K | -$539.00K | +84.7% |
| Pre-tax income | -$3.80M | -$8.02M | -$7.00M | -$3.69M | -$4.68M | +52.6% |
| Tax provision | $1.37M | -$622.00K | -$157.00K | $779.00K | $0 | +320.9% |
| Net income | -$5.17M | -$7.40M | -$6.84M | -$4.47M | $3.97M | +30.0% |
| Net income to common | -$5.17M | -$7.40M | -$6.84M | -$4.47M | $3.97M | +30.0% |
| Basic EPS | -0.42 | — | -1.60 | -1.10 | 1.10 | — |
| Diluted EPS | -0.42 | — | -1.60 | -1.10 | 1.10 | — |
| EBIT | -$3.15M | -$3.76M | -$5.45M | -$3.11M | -$4.14M | +16.3% |
| EBITDA | -$2.19M | $1.29M | -$5.45M | -$1.67M | -$2.54M | -269.2% |
| Basic shares | 12.32M | — | 4.15M | 4.15M | 3.52M | — |
| Diluted shares | 12.32M | — | 4.15M | 4.15M | 3.52M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $31.00K | $90.00K | $405.00K | $169.00K | $88.00K | — | -65.6% |
| Cash & short-term investments | $31.00K | $90.00K | $405.00K | $171.00K | $88.00K | — | -65.6% |
| Accounts receivable | $1.54M | $2.56M | $3.28M | $20.09M | $20.20M | — | -39.7% |
| Inventory | $70.00K | $70.00K | $266.00K | $830.00K | $1.15M | — | 0.0% |
| Total current assets | $3.11M | $3.15M | $7.77M | $24.57M | $24.77M | — | -1.2% |
| Property, plant & equipment | $1.71M | $2.03M | $2.35M | $3.63M | $10.56M | — | -15.9% |
| Goodwill & intangibles | $10.49M | $11.13M | $11.78M | $13.69M | $14.34M | — | -5.8% |
| Total assets | $58.73M | $59.87M | $65.70M | $42.04M | $50.11M | — | -1.9% |
| Total current liabilities | $56.11M | $53.08M | $55.29M | $25.63M | $24.05M | — | +5.7% |
| Current debt | $5.41M | $5.16M | $4.14M | $2.81M | $2.45M | — | +4.9% |
| Long-term debt | — | — | — | $436.00K | $1.83M | $11.65M | — |
| Total debt | $8.91M | $8.62M | $7.68M | $7.87M | $14.01M | — | +3.4% |
| Total liabilities | $59.34M | $56.36M | $58.84M | $30.61M | $34.99M | — | +5.3% |
| Retained earnings | -$78.49M | -$73.14M | -$65.74M | -$58.90M | -$54.43M | — | -7.3% |
| Shareholder equity | -$614.00K | $3.51M | $6.86M | $11.44M | $15.12M | — | -117.5% |
| Working capital | -$52.99M | -$49.93M | -$47.51M | -$1.05M | $718.00K | — | -6.1% |
| Net tangible assets | -$11.10M | -$7.63M | -$4.92M | -$2.25M | $783.00K | — | -45.6% |
| Shares issued | 14.89M | 9.84M | 5.02M | 5.02M | 5.02M | — | +51.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$5.17M | -$23.37M | $9.13M | -$4.47M | -$4.68M | — | +77.9% |
| Depreciation & amortisation | $962.00K | $5.05M | -$3.04M | $1.44M | $1.60M | — | -81.0% |
| Stock-based compensation | $390.00K | $1.89M | -$1.03M | $508.00K | $521.00K | — | -79.4% |
| Change in working capital | $2.00M | -$182.53K | $1.43M | $844.00K | -$2.27M | — | +1,197.9% |
| Operating cash flow | -$748.00K | -$8.34M | $3.62M | -$247.00K | -$3.38M | — | +91.0% |
| Investing cash flow | $12.00K | $919.08K | -$919.08K | $67.00K | $853.00K | — | -98.7% |
| Share buybacks | — | — | — | — | — | $0 | — |
| Financing cash flow | $677.00K | $6.83M | -$2.19M | $261.00K | $1.94M | — | -90.1% |
| Free cash flow | -$748.00K | -$8.34M | $3.62M | -$247.00K | -$3.38M | — | +91.0% |
| End cash position | $31.00K | $90.00K | $405 | $169.00K | $88.00K | — | -65.6% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2025 | -1.50 | -0.81 | +46.1% |
| Mar 2025 | -1.80 | -1.21 | +33.1% |
| Dec 2024 | -2.40 | -15.90 | -562.5% |
| Sep 2024 | -3.10 | -3.50 | -12.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders2.13%
Held by institutions0.06%
Institutions holding4
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 21, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 10, 23 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 14, 23 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 2, 23 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 12, 23 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Mar 8, 23 | HC Wainwright & Co. | MAINTAINED | — | Buy |
| Feb 23, 23 | HC Wainwright & Co. | MAINTAINED | — | Buy |
| Feb 16, 23 | HC Wainwright & Co. | MAINTAINED | — | Buy |
| Feb 7, 23 | HC Wainwright & Co. | MAINTAINED | — | Buy |
| Nov 11, 22 | HC Wainwright & Co. | MAINTAINED | — | Buy |
| May 17, 22 | HC Wainwright & Co. | MAINTAINED | — | Buy |
| Mar 31, 22 | HC Wainwright & Co. | MAINTAINED | — | Buy |
Moving averages & technicals
SMA 10
0.04
-44.44% from price
SMA 20
0.04
-52.94% from price
SMA 50
0.06
-69.04% from price
SMA 100
0.09
-77.78% from price
SMA 200
0.43
-95.36% from price
EMA 12
0.04
-43.72% from price
EMA 26
0.05
-57.22% from price
EMA 50
0.07
-69.23% from price
RSI (14)
28.8
Oversold
MACD (12,26,9)
-0.01
Hist -0.00
ATR (14)
0.01
46.43% of price
Realised vol 30D
234.4%
Annualised
Bollinger upper
0.06
20, 2σ
Bollinger lower
0.02
20, 2σ
50 / 200 cross
Death
0.06 vs 0.43
Trend bias
Below 200
-95.36%
Risk profile
Beta vs SPY
0.77
Less volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
234.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-99.7%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.01
46.43% of price
Beta (reported)
—
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend dateMay 24, 2022
Next pay dateJun 3, 2022
Last split1:10
Split dateDec 22, 2025
SEC filings
Periodic Financial Reports
10-Q · 2026-08-19
Periodic Financial Reports
NT 10-Q · 2026-08-14
Corporate Changes & Voting Matters
8-K · 2026-08-06
Periodic Financial Reports
10-Q/A · 2026-07-09
Periodic Financial Reports
10-Q/A · 2026-07-07
Periodic Financial Reports
10-Q · 2026-06-30
Periodic Financial Reports
10-K · 2026-06-01
Periodic Financial Reports
NT 10-Q · 2026-05-15
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.